The use of benzodiazepines in the context of Coronavirus related severe acute respiratory syndrome: a case report

Descrição

Tipo

Artigo de periódico

Título alternativo

Primeiro orientador

Membros da banca

Resumo

COVID-19 pandemic increased depression and anxiety worldwide and, although benzodiazepines are effective against acute anxiety, they are known to compromise respiratory physiology. Currently, however, no firm guidelines for benzodiazepine use in people with acute COVID-19 are available and there is sparse medical literature regarding benzodiazepine use in patients with active COVID-19 infection and acute anxiety symptoms. Therefore, we report in this correspondence a remarkable case regarding the parsimonious yet safe use of lorazepam for recurrent panic attacks during the course of active COVID-19 infection with severe acute respiratory syndrome. Benzodiazepines not only ceased panic attacks, but also improved respiratory parameters, as patient became less agitated and stopped manipulating his noninvasive ventilation devices. We further performed a narrative review of the literature, searching for studies regarding benzodiazepine use for acute anxiety in patients with COVID-19.

Abstract

Assunto

Covid-19, Ansiedade, Pânico, Benzodiazepinas

Palavras-chave

Covid-19, Anxiety, Panic, Benzodiazepine, Respiratory

Citação

Curso

Endereço externo

https://www.mathewsopenaccess.com/full-text/the-use-of-benzodiazepines-in-the-context-of-coronavirus-related-severe-acute-respiratory-syndrome-a-case-report

Avaliação

Revisão

Suplementado Por

Referenciado Por